相互作用
Upadacitinib + Vedolizumab
重症度: 重大
Upadacitinib and Vedolizumab: major interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Using a JAK inhibitor with another biologic immunosuppressant increases the risk of serious infection. Vedolizumab acts mainly in the gut, so systemic effects are smaller, but combination data are limited.
この相互作用をわかりやすく説明すると
Upadacitinib and Vedolizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Upadacitinib belongs to Musculoskeletal; Vedolizumab belongs to Gastrointestinal Tract.
なぜ起こるのか
Additive immunosuppression via gut-selective integrin blockade and JAK inhibition.
対処法
Avoid routine concurrent use; the upadacitinib label advises against combination with biologic immunosuppressants. If combined, monitor closely for infection.
薬剤師に尋ねること
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、UpadacitinibとVedolizumabの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を7日間無料でお試し。カード登録不要。
Vedolizumabのその他の相互作用
Upadacitinibのその他の相互作用
よくある質問
Can I take Upadacitinib with Vedolizumab?
MediHelp rates the interaction as major. Upadacitinib and Vedolizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Using a JAK inhibitor with another biologic immunosuppressant increases the risk of serious infection. Vedolizumab acts mainly in the gut, so systemic effects are smaller, but combination data are limited.
How serious is the interaction between Upadacitinib and Vedolizumab?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid routine concurrent use; the upadacitinib label advises against combination with biologic immunosuppressants. If combined, monitor closely for infection.
What other medicines interact with Vedolizumab?
MediHelp also lists interactions of Vedolizumab with, for example, Natalizumab, Baricitinib, Certolizumab pegol. The full list is on the Vedolizumab page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
